Nanoparticle formulation of bioflavonoids for enhanced anti-cancer activity

N/ACitations
Citations of this article
42Readers
Mendeley users who have this article in their library.

Abstract

Among the natural sources, plant origin drugs constitute around 25% which includes various secondary metabolites such as bioflavonoids, alkaloids, terpenes, saponins, glucosides, and lignans. The bioflavonoids belonging to the polyphenol group shows many beneficial effects like hepatoprotective, antioxidant, antibacterial, anticancer, anti-inflammatory and antiviral. The main objective of this article is to collectively present the research data published worldwide about the anticancer activity of bioflavonoids by loading them in novel formulations. Thus, the present review explored the novel formulations of the bioflavonoids with improved pharmacokinetic properties along with the enhanced anticancer activity. The major drawback with bioflavonoids is its poor solubility and bioavailability, which restricts the usage of bioflavonoids in the treatment of cancer in the market worldwide. Novel drug delivery system seems to possess many benefits like site-specific drug delivery along with minimal side effects and improves pharmaceutical and therapeutic properties of drugs compared to a conventional dosage form of bioflavonoids. The scope for improvement of anticancer activity of bioflavonoids by incorporating in novel pharmaceutical formulations like nanoparticles is very high, and it has to be considered as a potential area of research.

Cite

CITATION STYLE

APA

Kumar, S. S., Shanmugasundaram, P., Komala, M., Bhargavi, B., & Padmavathy, J. (2020). Nanoparticle formulation of bioflavonoids for enhanced anti-cancer activity. International Journal of Applied Pharmaceutics, 12(5), 29–35. https://doi.org/10.22159/ijap.2020v12i5.38425

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free